MedPath

Rinicare Ltd.

Rinicare Ltd. logo
🇬🇧United Kingdom
Ownership
Holding
Established
2002-01-01
Employees
51
Market Cap
-
Website
http://www.rinicare.com

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Controlled Trial to Demonstrate a Reduction in the Number of Oliguria Events in Patients Being Managed in a Critical Care Unit, Following Cardiac Surgery, When a Novel Oliguria Prediction Tool (STABILITY UO) is Used to Identify Patients at Risk, Compared to Standard of Care.

Not Applicable
Conditions
Acute Kidney Injury
First Posted Date
2021-08-12
Last Posted Date
2022-04-28
Lead Sponsor
Rinicare Ltd
Target Recruit Count
362
Registration Number
NCT05001503
Locations
🇬🇧

Wythenshawe Hospital (Manchester University NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

System to Avoid Fall Events

Conditions
Accidental Fall
First Posted Date
2018-02-01
Last Posted Date
2018-04-11
Lead Sponsor
Rinicare Ltd
Target Recruit Count
50
Registration Number
NCT03418103

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.